Pamapimod: A proof-of-concept and drug-drug interaction study of pamapimod, a novel p38 MAP kinase inhibitor, with methotrexate in patients with rheumatoid arthritis
Microrna21
MiRNAs appear to target about 60% of the genes of humans and other mammals.
